Additional noncontingent settlement amount pending

Name: Arbutus Biopharma Corporation Additional noncontingent settlement amount pending by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Arbutus Biopharma Corporation·Products & Services·1 segment

Breakdown

Segment	Q1 '26
Revenue from collaborations and licenses	$1.3B
Total	$1.3B

Segments

Revenue from collaborations and licensesView metric